resveratrol has been researched along with Diabetic Cardiomyopathies in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 17 (80.95) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, WJ; Li, XM; Xiong, Y; Zhou, XK | 1 |
| Song, YJ; Wu, W; Zhong, CB | 1 |
| Ahmad, I; Hoda, M | 1 |
| Chang, RL; Chen, TS; Chuang, SY; Ho, TJ; Huang, CY; Kuo, CH; Kuo, WW; Mahalakshmi, B; Shen, CY; Yeh, YL | 1 |
| Chen, M; Huang, A; Liu, B; Liu, Q; Ou, C; Wu, Z; Yan, J; Zhang, J; Zhang, X | 1 |
| Fang, WJ; He, Y; Liu, SK; Peng, XD; Wang, CJ; Zhou, YL | 1 |
| Cao, F; Chen, J; Fan, M; Feng, J; Han, D; Li, C; Li, X; Ma, S; Tian, Z; Wang, Y; Yang, B; Zhang, R | 1 |
| Chen, T; Huang, W; Liang, G; Qian, J; Sun, C; Wang, J; Xu, Z; Ye, S; You, S; Zhang, H | 1 |
| Li, Z; Liu, B; Song, X; Wang, G; Zhao, L | 1 |
| Guo, S; Ke, ZQ; Liu, C; Liu, XF; Xu, K; Yao, Q | 1 |
| Chen, M; Diao, J; Fan, G; Lin, L; Wei, J; Yan, R | 1 |
| Aabdelbaset, M; Ammar, HI; Ashour, H; Fadel, M; Kamar, SS; Rashed, LA; ShamsEldeen, AM; Shoukry, HS | 1 |
| Bernard, M; Desrois, M; Fourny, N; Lan, C; Sérée, E | 1 |
| Haidari, F; Mohammadshahi, M; Soufi, FG | 1 |
| Arkell, AM; Beaudoin, MS; Chabowski, A; Holloway, GP; Perry, CG; Simpson, JA; Wright, DC | 1 |
| Dyck, JR; Hamza, SM; Sung, MM | 1 |
| Guo, R; Li, W; Liu, B; Liu, W; Xu, Y; Zhang, B | 1 |
| Chen, JZ; Chen, QH; Kang, LN; Li, GN; Li, R; Wei, ZH; Wu, H; Xie, J; Xu, B | 1 |
| Chen, L; Li, GN; Li, R; Sheng, ZQ; Wang, L; Wu, H; Xie, J; Xu, B | 1 |
| Chen, S; Deng, W; Fan, YL; Liao, HH; Liu, HJ; Liu, Y; Ma, ZG; Tang, QZ; Yang, Z; Zhang, N | 1 |
| Chang, CC; Day, YJ; Deng, JY; Huang, JP; Huang, SS; Hung, LM | 1 |
3 review(s) available for resveratrol and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Resveratrol and Diabetic Cardiomyopathy: Focusing on the Protective Signaling Mechanisms.
Topics: Antioxidants; Diabetic Cardiomyopathies; Humans; Resveratrol; Signal Transduction | 2020 |
Molecular mechanisms of action of resveratrol in modulation of diabetic and non-diabetic cardiomyopathy.
Topics: Animals; Antioxidants; Cardiomyopathies; Diabetic Cardiomyopathies; Disease Models, Animal; Humans; Myocytes, Cardiac; Oxidative Stress; Resveratrol; Signal Transduction | 2020 |
Myocardial metabolism in diabetic cardiomyopathy: potential therapeutic targets.
Topics: Animals; Antioxidants; Diabetes Mellitus; Diabetic Cardiomyopathies; Humans; Mitochondria; Myocardium; Resveratrol; Stilbenes | 2015 |
18 other study(ies) available for resveratrol and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Resveratrol improves diabetic cardiomyopathy by preventing asymmetric dimethylarginine-caused peroxisome proliferator-activated receptor-γ coactivator-1α acetylation.
Topics: Acetylation; Animals; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Myocytes, Cardiac; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Rats; Resveratrol; Sirtuin 1 | 2022 |
Antioxidant Sirt1/Akt axis expression in resveratrol pretreated adipose-derived stem cells increases regenerative capability in a rat model with cardiomyopathy induced by diabetes mellitus.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Antioxidants; Cell Communication; Cell Line; Cell Proliferation; Coculture Techniques; Diabetic Cardiomyopathies; Disease Models, Animal; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Rats, Wistar; Regeneration; Resveratrol; Signal Transduction; Sirtuin 1; Ventricular Function, Left | 2021 |
Resveratrol Ameliorates Cardiac Dysfunction by Inhibiting Apoptosis via the PI3K/Akt/FoxO3a Pathway in a Rat Model of Diabetic Cardiomyopathy.
Topics: Animals; Apoptosis; Diabetic Cardiomyopathies; Disease Models, Animal; Forkhead Box Protein O3; Male; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation.
Topics: Acetylation; Animals; Antioxidants; Cardiomegaly; Cardiotonic Agents; Cell Line; Diabetic Cardiomyopathies; Male; Mitochondria; Organelle Biogenesis; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes; Uncoupling Protein 2; Ventricular Function, Left | 2018 |
SIRT1 Activation by Resveratrol Alleviates Cardiac Dysfunction via Mitochondrial Regulation in Diabetic Cardiomyopathy Mice.
Topics: Animals; Cell Line; Diabetic Cardiomyopathies; DNA-Binding Proteins; ERRalpha Estrogen-Related Receptor; Humans; Mice; Mice, Knockout; Mice, Transgenic; Mitochondria; Mitochondrial Proteins; NF-E2-Related Factor 1; Receptors, Estrogen; Resveratrol; Sirtuin 1; Stilbenes; Transcription Factors | 2017 |
An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Cardiovascular Agents; Cell Line; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Gene Expression Regulation; Glucose; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Rats; Resveratrol; Signal Transduction; Streptozocin | 2018 |
Resveratrol Prevents Diabetic Cardiomyopathy by Increasing Nrf2 Expression and Transcriptional Activity.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Gene Expression Regulation; Male; Mice; NF-E2-Related Factor 2; Resveratrol; Stilbenes; Transcription, Genetic | 2018 |
Resveratrol Modulates Apoptosis and Autophagy Induced by High Glucose and Palmitate in Cardiac Cells.
Topics: Animals; Antioxidants; Apoptosis; Autophagy; Cell Line; Diabetic Cardiomyopathies; Glucose; Hyperglycemia; Myoblasts, Cardiac; Palmitates; Rats; Resveratrol; Stilbenes | 2018 |
Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
Topics: Animals; Antioxidants; Apoptosis; Cardiotonic Agents; Cell Line; Cholesterol, LDL; Cytochromes c; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diet, High-Fat; Gene Expression Regulation; Glucose; Insulin Resistance; Male; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Streptozocin; Triglycerides; Uncoupling Protein 2 | 2019 |
Combined treatment with systemic resveratrol and resveratrol preconditioned mesenchymal stem cells, maximizes antifibrotic action in diabetic cardiomyopathy.
Topics: Animals; Antioxidants; Bone Malalignment; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Random Allocation; Rats; Rats, Wistar; Resveratrol | 2019 |
Protective Effect of Resveratrol against Ischemia-Reperfusion Injury via Enhanced High Energy Compounds and eNOS-SIRT1 Expression in Type 2 Diabetic Female Rat Heart.
Topics: Adenosine Triphosphate; Animals; Cardiotonic Agents; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Energy Metabolism; Female; Gene Expression; Magnetic Resonance Spectroscopy; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphocreatine; Rats; Rats, Wistar; Resveratrol; Sirtuin 1 | 2019 |
Chronic resveratrol administration improves diabetic cardiomyopathy in part by reducing oxidative stress.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Dose-Response Relationship, Drug; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Ribonucleotide Reductases; Stilbenes | 2014 |
Impairments in mitochondrial palmitoyl-CoA respiratory kinetics that precede development of diabetic cardiomyopathy are prevented by resveratrol in ZDF rats.
Topics: Animals; Cardiotonic Agents; Diabetic Cardiomyopathies; Electron Transport Chain Complex Proteins; Fibrosis; Glutathione; Glutathione Disulfide; Heart Ventricles; Kinetics; Lipid Metabolism; Male; Mitochondria, Heart; Palmitoyl Coenzyme A; Rats, Zucker; Resveratrol; Stilbenes; Ventricular Function, Left | 2014 |
SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: An insight into endoplasmic reticulum stress response mechanism.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diet, High-Fat; Endoplasmic Reticulum Stress; Enzyme Inhibitors; Male; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Small Interfering; Sirtuin 1; Stilbenes; Unfolded Protein Response | 2015 |
Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice.
Topics: Animals; Antioxidants; Cell Adhesion Molecules; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Heart; Male; MAP Kinase Signaling System; Mice; Myocardium; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes; Transforming Growth Factor beta | 2016 |
Reduced HMGB 1-Mediated Pathway and Oxidative Stress in Resveratrol-Treated Diabetic Mice: A Possible Mechanism of Cardioprotection of Resveratrol in Diabetes Mellitus.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Fibrosis; Heart; HMGB1 Protein; Inflammation; Male; Membrane Glycoproteins; Mice; Monocytes; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Protective Agents; Resveratrol; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Stilbenes | 2016 |
Apigenin alleviates STZ-induced diabetic cardiomyopathy.
Topics: Animals; Antioxidants; Apigenin; Cardiotonic Agents; Cell Line; Diabetic Cardiomyopathies; Gene Expression Regulation; Humans; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Rats; Resveratrol; Stilbenes; Streptozocin | 2017 |
Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin.
Topics: Acute Disease; Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Drug Antagonism; Drug Evaluation, Preclinical; Drug Synergism; Heart Failure; Hemodynamics; Hypoglycemic Agents; Insulin; Male; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Streptozocin; Vasodilator Agents | 2010 |